|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WHO005726484 |
| 003 |
DE-627 |
| 005 |
20210519005054.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2020 xx |||||o 00| ||und c |
| 035 |
|
|
|a (DE-627)WHO005726484
|
| 035 |
|
|
|a (DE-599)UBBS_Klinische_Studien_WHOISRCTN33260034
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)ISRCTN33260034
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)2020-003628-18
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)Nil known
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)IRAS 287434
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a und
|
| 082 |
0 |
|
|a 610
|
| 245 |
1 |
0 |
|a Adalimumab for coronavirus in community care
|b Adalimumab in COVID-19 to prevent respiratory failure in community care (AVID-CC): A randomised controlled trial
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), Registered on 20/08/2020, Last updated on 2021-04-29
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2020) vom: 07. Sept.
|
| 773 |
1 |
8 |
|g year:2020
|g day:07
|g month:09
|
| 856 |
4 |
0 |
|u http://isrctn.com/ISRCTN33260034
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2020
|b 07
|c 09
|
| 953 |
|
|
|2 045F
|a 610
|
Klinische Studie